我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
1
1 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
N/A
进行中（未招募）
100.0%
暂无批准数据
- Okeiro (formerly Predict4Health) has raised €10 million in funding led by Alven, Forepont Capital Partners, and Red River West to expand its AI-powered clinical decision support platform internationally. - The company's proprietary iBox algorithm, recognized as a surrogate endpoint by FDA and EMA, enables early prediction of transplant rejection and has already been implemented in leading French transplant centers. - Okeiro is conducting a multi-center randomized clinical trial across 16 hospitals in 6 countries to validate its technology's effectiveness compared to standard care protocols.
